International Biotechnology Trust plc Discusses Biotech Sector Outlook for 2026

Fund managers share insights from the JPMorgan Healthcare Conference

Published on Feb. 10, 2026

Got story updates? Submit your updates here. ›

International Biotechnology Trust plc (IBITF) held a webinar to discuss the outlook and investment themes for the biotechnology sector in 2026. The webinar featured fund managers Ailsa Craig and Marek Poszepczynski, who recently attended the JPMorgan Healthcare Conference in San Francisco to gather insights on industry trends. The trust has outperformed its benchmark for the past four fiscal years and was the top-performing trust in its sector in 2025.

Why it matters

The biotechnology sector is a key driver of innovation in the healthcare industry, with new advancements in areas like gene therapy, immunotherapy, and precision medicine. Understanding the sector's outlook and investment themes can help investors make informed decisions about allocating capital to this dynamic and rapidly evolving market.

The details

During the webinar, the fund managers will share their perspectives on the current state of the biotechnology sector and the key investment themes they are focusing on for 2026. This includes insights gathered from the JPMorgan Healthcare Conference, which is a major industry event that brings together biotechnology companies, investors, and other stakeholders to discuss the latest developments and trends.

  • The webinar took place on February 10, 2026.
  • The fund managers attended the JPMorgan Healthcare Conference prior to the webinar.

The players

Roland Jones

An investment trust specialist at Schroders, the asset management firm that oversees the International Biotechnology Trust plc.

Ailsa Craig

One of the fund managers for the International Biotechnology Trust plc.

Marek Poszepczynski

One of the fund managers for the International Biotechnology Trust plc.

International Biotechnology Trust plc (IBITF)

A closed-end investment trust that focuses on investing in the global biotechnology sector.

Schroders

The asset management firm that oversees the International Biotechnology Trust plc.

Got photos? Submit your photos here. ›

What they’re saying

“We do these conferences, these webinars every year, around about this time because Ailsa and Marek go to San Francisco for the JPMorgan Healthcare Conference. And it's always a really good event to pick up sentiments and theme and the tone for the year.”

— Roland Jones, Investment trust specialist at Schroders (Seeking Alpha)

What’s next

The fund managers will likely provide more detailed insights and analysis on the key investment themes and outlook for the biotechnology sector during the webinar presentation.

The takeaway

The International Biotechnology Trust plc has demonstrated strong performance in recent years, outperforming its benchmark consistently. The upcoming webinar provides an opportunity for investors to gain valuable insights from the fund managers on the current state and future prospects of the dynamic biotechnology sector.